ISMA-RHINA 2024

Back
05 - 06 September 2024 Helsinki, Finland

OA1 - Intralymphatic immunotherapy with aluminium hydroxide based grass allergen reduced medication use in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial

Thursday 05 Sep, 10:30 AM - 10:42 AM Helsinki, Finland